Search
for
Sort by
Research 481–510 of 1000+
- A review of Janus kinase inhibitor use in scarring alopecia
- International evidence‐based guideline on assessment and management of PCOS—A Nordic perspective
- COVID-19: The question of genetic diversity and therapeutic intervention approaches
- Role of Extracellular Vesicles as Mediators of Cell Communication and Novel Biomarkers in Sepsis
- Identifying long-term effects of SARS-CoV-2 and their association with social determinants of health in a cohort of over one million COVID-19 survivors
- Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus
- Global Impact of Coronavirus Disease 2019 (COVID-19)
- Systemic Lupus Erythematosus: What Every Clinician Needs to Know
- Management of long COVID-19 in children and adolescents: from diagnosis to therapeutically approaches
- A Case Report of Discoid Lupus Erythematosus Mimicking Skin Infection
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Delphi Consensus on Attenuated Androgen Use for Long‐Term Prophylaxis in Hereditary Angioedema: AURA Project
- Endocrine Management of Adult Gender-Dysphoric/Gender-Incongruent Persons: A Clinical Practice Guideline from Endocrine Society of India
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- The Multisystem Impact of Long COVID: A Comprehensive Review
- Referee report. For: Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus [version 2; peer review: 2 approved]
- Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus
- Referee report. For: Case Report: Extensive digital gangrene as a primary manifestation of late-onset systemic lupus erythematosus [version 2; peer review: 1 approved]
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Pathological sequelae of long-haul COVID
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- The Skin Microbiome: Current Landscape and Future Opportunities
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- The Many Faces of Calcineurin Inhibitor Toxicity—What the FK?
- Stroke Risk Factors Unique to Women
- Targeting integrin pathways: mechanisms and advances in therapy
- Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
- Hormonal Contraceptives and Dermatology
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Potential Therapeutic Applications of Bee Venom on Skin Disease and Its Mechanisms: A Literature Review